Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 14, Issue 4, 2015, Pages 468-473

  Zhao, Jiangchao ^a   Evans, Charles R ^a   Carmody, Lisa A ^a   LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cystic fibrosis; Metabolome; Sputum

Indexed keywords

PHENAZINE DERIVATIVE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; HEALTH STATUS; HUMAN; IN VIVO STUDY; LIQUID CHROMATOGRAPH; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; MICROBIOME; PSEUDOMONAS; QUORUM SENSING; RESPIRATORY TRACT INFECTION; ROOM TEMPERATURE; SPUTUM ANALYSIS; SPUTUM STORAGE; STORAGE; STORAGE TEMPERATURE; BIOBANK; CRYOPRESERVATION; METABOLISM; METABOLOME; MICROBIOLOGY; MICROFLORA; PROCEDURES; SPECIMEN HANDLING; SPUTUM; TEMPERATURE;

BIOLOGICAL SPECIMEN BANKS; CRYOPRESERVATION; CYSTIC FIBROSIS; HUMANS; METABOLOME; MICROBIOTA; SPECIMEN HANDLING; SPUTUM; TEMPERATURE;

EID: 84937633740     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.02.004     Document Type: Article

References (29)

1. Carmody L.A., Zhao J., Schloss P.D., Petrosino J.F., Murray S., Young V.B., et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 2013, 10:179-187.
2. Zhao J., Schloss P.D., Kalikin L.M., Carmody L.A., Foster B.K., Petrosino J.F., et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 2012, 109:5809-5814.
3. Stressmann F.A., Rogers G.B., van der Gast C.J., Marsh P., Vermeer L.S., Carroll M.P., et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012, 67:867-873.
4. Brown P.S., Pope C.E., Marsh R.L., Qin X., McNamara S., Gibson R., et al. Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc 2014, 11:1049-1055.
5. Hampton T.H., Green D.M., Cutting G.R., Morrison H.G., Sogin M.L., Gifford A.H., et al. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome 2014, 2:14.
6. Price K.E., Hampton T.H., Gifford A.H., Dolben E.L., Hogan D.A., Morrison H.G., et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 2013, 1:27.
7. Deschaght P., Schelstraete P., Van Simaey L., Vanderkercken M., Raman A., Mahieu L., et al. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?. PLoS One 2013, 8:e79010.
8. Fodor A.A., Klem E.R., Gilpin D.F., Elborn J.S., Boucher R.C., Tunney M.M., et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012, 7:e45001.
9. Twomey K.B., Alston M., An S.Q., O'Connell O.J., McCarthy Y., Swarbreck D., et al. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS One 2013, 8:e82432.
10. Zemanick E.T., Harris J.K., Wagner B.D., Robertson C.E., Sagel S.D., Stevens M.J., et al. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 2013, 8:e62917.
11. Zhao J., Carmody L.A., Kalikin L.M., Li J., Petrosino J.F., Schloss P.D., et al. Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One 2012, 7:e33127.
12. Salter S.J., Cox M.J., Turek E.M., Calus S.T., Cookson W.O., Moffatt M.F., et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014, 12:87.
13. Struss A.K., Nunes A., Waalen J., Lowery C.A., Pullanikat P., Denery J.R., et al. Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states. Anal Chem 2013, 85:3355-3362.
14. Yang J., Eiserich J.P., Cross C.E., Morrissey B.M., Hammock B.D. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med 2012, 53:160-171.
15. Kozlowska J., Rivett D.W., Vermeer L.S., Carroll M.P., Bruce K.D., Mason A.J., et al. A relationship between growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation. Metabolomics 2013, 9.
16. Wetmore D.R., Joseloff E., Pilewski J., Lee D.P., Lawton K.A., Mitchell M.W., et al. Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells. J Biol Chem 2010, 285:30516-30522.
17. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 2006, 78:743-752.
18. Kimball E., Rabinowitz J.D. Identifying decomposition products in extracts of cellular metabolites. Anal Biochem 2006, 358:273-280.
19. Buscher J.M., Czernik D., Ewald J.C., Sauer U., Zamboni N. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem 2009, 81:2135-2143.
20. Kozich J.J., Westcott S.L., Baxter N.T., Highlander S.K., Schloss P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013, 79:5112-5120.
21. Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009, 75:7537-7541.
22. Pluskal T., Castillo S., Villar-Briones A., Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinforma. 2010, 11:395.
23. Collier D.N., Anderson L., McKnight S.L., Noah T.L., Knowles M., Boucher R., et al. A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett 2002, 215:41-46.
24. Hunter R.C., Klepac-Ceraj V., Lorenzi M.M., Grotzinger H., Martin T.R., Newman D.K. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol 2012, 47:738-745.
25. Eiserich J.P., Yang J., Morrissey B.M., Hammock B.D., Cross C.E. Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions. Ann N Y Acad Sci 2012, 1259:1-9.
26. Whiteson K.L., Meinardi S., Lim Y.W., Schmieder R., Maughan H., Quinn R., et al. Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate Jactive pH neutral 2,3-butanedione fermentation. ISME J 2014, 8:1247-1258.
27. Zhao J., Li J., Schloss P.D., Kalikin L.M., Raymond T.A., Petrosino J.F., et al. Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens. J Clin Microbiol 2011, 49:3717-3718.
28. Diggle S.P., Cornelis P., Williams P., Camara M. 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol 2006, 296:83-91.
29. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., Greenberg E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764.